These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 2435999)
21. Nifedipine as an antihypertensive drug in patients with renal failure--pharmacokinetics and effects. Odar-Cederlöf I; Anderson P; Bondesson U J Intern Med; 1990 May; 227(5):329-37. PubMed ID: 2341826 [TBL] [Abstract][Full Text] [Related]
22. Rectal administration of nifedipine: haemodynamic effects and pharmacokinetics in hypertensives. Kurosawa S; Kurosawa N; Owada E; Matsuhashi N; Ito K J Int Med Res; 1987; 15(3):121-7. PubMed ID: 3609449 [TBL] [Abstract][Full Text] [Related]
23. Interaction between nifedipine and atenolol: pharmacokinetics and pharmacodynamics in normotensive volunteers. Rosenkranz B; Ledermann H; Frölich JC J Cardiovasc Pharmacol; 1986; 8(5):943-9. PubMed ID: 2429095 [TBL] [Abstract][Full Text] [Related]
24. Age-related changes in the pharmacokinetics and pharmacodynamics of nifedipine. Robertson DR; Waller DG; Renwick AG; George CF Br J Clin Pharmacol; 1988 Mar; 25(3):297-305. PubMed ID: 3358895 [TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and pharmacodynamics of nifedipine infusion in normal volunteers. Walley TJ; Heagerty AM; Woods KL; Bing RF; Pohl JE; Barnett DB Br J Clin Pharmacol; 1987 Jun; 23(6):693-701. PubMed ID: 3606929 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of ketanserin in patients with essential hypertension. Persson B; Pettersson A; Hedner T Eur J Clin Pharmacol; 1987; 32(3):259-65. PubMed ID: 3595699 [TBL] [Abstract][Full Text] [Related]
27. Comparison of two calcium blockers on hemodynamics, left ventricular mass, and coronary vasodilatory in advanced hypertension. Diamond JA; Krakoff LR; Goldman A; Coplan N; Gharavi A; Martin K; Goldsmith R; Henzlova MJ; Machac J; Phillips RA Am J Hypertens; 2001 Mar; 14(3):231-40. PubMed ID: 11281234 [TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics and pharmacodynamics of conventional and slow release forms of nifedipine in essential hypertensive patients. Imai Y; Abe K; Sasaki S; Nihei M; Sekino H; Yoshinaga K Tohoku J Exp Med; 1986 Apr; 148(4):421-38. PubMed ID: 3738908 [TBL] [Abstract][Full Text] [Related]
29. The haemodynamic effects of intravenous nifedipine in normotensive and hypertensive subjects. Walley TJ; Heagerty AM; Woods KL; Bing RF; Pohl JE; Barnett DB J Hum Hypertens; 1988 Oct; 2(3):199-202. PubMed ID: 3236324 [TBL] [Abstract][Full Text] [Related]
30. Acute effect of nifedipine on blood pressure and left ventricular ejection fraction in severely hypertensive outpatients: predictive effects of acute therapy and prolonged efficacy when added to existing therapy. Jennings AA; Jee LD; Smith JA; Commerford PJ; Opie LH Am Heart J; 1986 Mar; 111(3):557-63. PubMed ID: 2869672 [TBL] [Abstract][Full Text] [Related]
31. Antihypertensive effectiveness of nifedipine gastrointestinal therapeutic system in the elderly. The Modern Approach to the Treatment of Hypertension (MATH) Study Group. Bravo EL; Krakoff LR; Tuck ML; Friedman CP Am J Hypertens; 1990 Dec; 3(12 Pt 2):326S-332S. PubMed ID: 2078319 [TBL] [Abstract][Full Text] [Related]
32. Safety of the coadministration of carvedilol and nifedipine sustained-release in the treatment of essential hypertension. Juttmann JR; de Vries Robles P; Venuti RP J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S134-7. PubMed ID: 1378141 [TBL] [Abstract][Full Text] [Related]
33. Effects of amlodipine, a long-acting dihydropyridine calcium antagonist in aging hypertension: pharmacodynamics in relation to disposition. Abernethy DR; Gutkowska J; Winterbottom LM Clin Pharmacol Ther; 1990 Jul; 48(1):76-86. PubMed ID: 2142447 [TBL] [Abstract][Full Text] [Related]
34. Hemodynamic effects of nifedipine in hypertension in the presence of elevated angiotensin-II and beta-adrenergic blockade. Blau A; Battler A; Eldar M; Rath S; Neufeld HN; Kapuler S; Iaina A; Cohen D; Eliahou HE J Clin Hypertens; 1986 Mar; 2(1):13-20. PubMed ID: 2873210 [TBL] [Abstract][Full Text] [Related]
35. Hemodynamic comparison of two nifedipine formulations in patients with essential hypertension. Frohlich ED; McLoughlin MJ; Losem CJ; Ketelhut R; Messerli FH Am J Cardiol; 1991 Nov; 68(13):1346-50. PubMed ID: 1951124 [TBL] [Abstract][Full Text] [Related]
36. Influence of calcium administration on the short-term hemodynamic and anti-ischemic effects of nifedipine. Wohns DH; Patterson JH; Clarke S; Dunlap S; Blauwet MB; Koch G; Adams KF J Am Coll Cardiol; 1991 Oct; 18(4):1070-6. PubMed ID: 1894852 [TBL] [Abstract][Full Text] [Related]
37. Acute and chronic sympathetic reflex activation and antihypertensive response to nifedipine. Kiowski W; Erne P; Bertel O; Bolli P; Bühler F J Am Coll Cardiol; 1986 Feb; 7(2):344-8. PubMed ID: 3944353 [TBL] [Abstract][Full Text] [Related]
38. Trough and peak effects of a single daily dose of nifedipine gastrointestinal therapeutic system (GITS) as assessed by ambulatory blood pressure monitoring. Italian Nifedipine GITS Study Group. Zanchetti A J Hypertens Suppl; 1994 Jul; 12(5):S23-7. PubMed ID: 7965282 [TBL] [Abstract][Full Text] [Related]
39. Acute and long-term treatment of hypertension with nifedipine in the elderly. Dubiel JP; Kawecka-Jaszcz K; Kocemba J; Czarnecka D; Grodzicki T; Skoczen M; Skalska A; Witek J J Hum Hypertens; 1990 Aug; 4(4):410-4. PubMed ID: 2258886 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of nifedipine derived from a new retard tablet formulation. Avgerinos A; Gorrod JW Eur J Drug Metab Pharmacokinet; 1990; 15(4):273-8. PubMed ID: 2088764 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]